$AGIO 4 SEC Filings

Filed On	Filing
23 Oct 2026	Form 4: Gheuens Sarah, Chief Medical Officer Received 1,489 shares by exercise or conversion ($37.2K) · Sold 1,489 shares ($55.9K) · Received 500 shares by exercise or conversion ($12.5K) · 1 more
06 Aug 2026	Form 4: Gheuens Sarah, Chief Medical Officer Sold 30,000 shares ($914K)
10 Jul 2026	Form 4: Backstrom Jay T., Director Received 1,447 shares as a grant or award · Exercised 1,447 Restricted stock units
02 Jul 2026	Form 4: Gheuens Sarah, Chief Medical Officer Received 8,375 shares by exercise or conversion · Sold 4,007 shares ($151K)
23 Jun 2026	Form 4: Scadden David, Director Received 2,816 shares by exercise or conversion · Granted 2,927 Restricted stock units · Granted 14,950 Stock options (right to buy)
23 Jun 2026	Form 4: Smith Cynthia, Director Received 2,816 shares by exercise or conversion · Granted 2,927 Restricted stock units · Granted 14,950 Stock options (right to buy)
23 Jun 2026	Form 4: Viswanadhan Krishnan, Chief Strategy and Operations Exercised 3,000 Performance share units · Granted 3,000 Restricted stock units
23 Jun 2026	Form 4: Goff Brian, Director Exercised 39,000 Performance share units · Granted 39,000 Restricted stock units
23 Jun 2026	Form 4: Burns James William, Chief Legal Officer Exercised 3,000 Performance share units · Granted 3,000 Restricted stock units
23 Jun 2026	Form 4: Gheuens Sarah, Chief Medical Officer Exercised 3,000 Performance share units · Granted 3,000 Restricted stock units
23 Jun 2026	Form 4: Jones Cecilia, Chief Financial Officer Exercised 3,000 Performance share units · Granted 3,000 Restricted stock units
23 Jun 2026	Form 4: Milanova Tsveta, Chief Commercial Officer Exercised 3,000 Performance share units · Granted 3,000 Restricted stock units
23 Jun 2026	Form 4: Backstrom Jay T., Director Granted 2,927 Restricted stock units · Granted 14,950 Stock options (right to buy)
23 Jun 2026	Form 4: Owen Adams Catherine, Director Received 2,816 shares by exercise or conversion · Granted 2,927 Restricted stock units · Granted 14,950 Stock options (right to buy)
23 Jun 2026	Form 4: Ballal Rahul D., Director Received 2,816 shares by exercise or conversion · Granted 2,927 Restricted stock units · Granted 14,950 Stock options (right to buy)
23 Jun 2026	Form 4: Capello Jeffrey D, Director Received 2,816 shares by exercise or conversion · Granted 2,927 Restricted stock units · Granted 14,950 Stock options (right to buy)
23 Jun 2026	Form 4: Foster-Cheek Kaye I, Director Received 2,816 shares by exercise or conversion · Granted 2,927 Restricted stock units · Granted 14,950 Stock options (right to buy)
23 Jun 2026	Form 4: Fouse Jacqualyn A, Director Received 2,816 shares by exercise or conversion · Granted 2,927 Restricted stock units · Granted 14,950 Stock options (right to buy)
23 Jun 2026	Form 4: Ho Maykin, Director Received 2,816 shares by exercise or conversion · Granted 2,927 Restricted stock units · Granted 14,950 Stock options (right to buy)
16 Jun 2026	Form 4: Owen Adams Catherine, Director Received 1,976 shares by exercise or conversion

Comments